 | -$0.37 Earnings Per Share Expected for Xenon Pharmaceuticals Inc (XENE) This Quarter
www.americanbankingnews.com - February 13 at 9:12 PM |
 | Xenon updates on two CNS pipeline candidates; shares up 2%
seekingalpha.com - January 28 at 6:20 PM |
 | Xenon Provides Key Regulatory Updates on XEN007 and XEN1101
finance.yahoo.com - January 28 at 8:18 AM |
 | What Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock? - Yahoo Finance UK
uk.finance.yahoo.com - January 20 at 8:19 AM |
| What Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock?
finance.yahoo.com - January 18 at 5:43 PM |
| Xenon Pharmaceuticals Outlines 2019 Key Milestones
finance.yahoo.com - January 7 at 8:16 AM |
| Xenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual Meeting
finance.yahoo.com - December 3 at 8:20 AM |
| Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) Meeting
finance.yahoo.com - November 30 at 5:52 PM |
| Is Xenon Pharmaceuticals Inc (NASDAQ:XENE) Overpaying Its CEO?
finance.yahoo.com - November 15 at 5:25 PM |
| Investor Expectations to Drive Momentum within The York Water, Canon, Peak Resorts, Volt Information Sciences, LSI Industries, and Xenon Pharmaceuticals — Discovering Underlying Factors of Influence
finance.yahoo.com - November 15 at 8:21 AM |
| Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 5:30 PM |
| Xenon Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 5:46 PM |
| Xenon Pharmaceuticals: 3Q Earnings Snapshot
finance.yahoo.com - November 7 at 8:21 AM |
| Edited Transcript of XENE earnings conference call or presentation 6-Nov-18 9:30pm GMT
finance.yahoo.com - November 7 at 8:21 AM |
| Xenon Pharma misses by $0.18
seekingalpha.com - November 6 at 5:32 PM |
| Xenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 5:32 PM |
| Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - October 30 at 5:32 PM |
| Xenon Pharma closes $63M stock offering
seekingalpha.com - September 17 at 5:17 PM |
| Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares
finance.yahoo.com - September 17 at 5:17 PM |
 | Xenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common Shares
www.streetinsider.com - September 13 at 4:53 PM |
| Xenon Pharmaceuticals prices $63M public offering of common shares
seekingalpha.com - September 13 at 4:53 PM |
| Form 8-K Xenon Pharmaceuticals For: Sep 12
www.streetinsider.com - September 13 at 8:27 AM |
| Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)
www.streetinsider.com - September 12 at 8:20 AM |
| Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
finance.yahoo.com - September 11 at 8:24 AM |
| Xenon: An Updated Investment Analysis
seekingalpha.com - September 10 at 4:56 PM |
| Is Xenon Pharmaceuticals A Stock To Consider?
seekingalpha.com - September 8 at 8:18 AM |
| Xenon Pharma up 15% on new pipeline candidate
seekingalpha.com - September 7 at 5:06 PM |
| Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy
seekingalpha.com - September 6 at 8:26 AM |
| Xenon Pharmaceuticals (XENE) Plans XEN496 Pivotal Phase 3 Trial in mid-2019
www.streetinsider.com - September 6 at 8:26 AM |
| Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy
finance.yahoo.com - September 6 at 8:26 AM |
 | Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a "Phase 3 Ready" Potassium Channel Modulator for the Treatment of Epilepsy
feeds.benzinga.com - September 6 at 7:44 AM |
| Xenon Pharmaceuticals (XENE) Provides Financial Support For The Study Of The New Antiepileptic Drug XEN1101 - Slideshow
seekingalpha.com - August 29 at 4:58 PM |
| Edited Transcript of XENE earnings conference call or presentation 7-Aug-18 8:30pm GMT
finance.yahoo.com - August 19 at 8:29 AM |
| Xenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 5:06 PM |
| Xenon Pharmaceuticals: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 8:26 AM |
| Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 8:26 AM |
| Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 5:24 PM |
| Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - August 3 at 4:31 PM |
| Xenon Pharma inks $50M stock sales agreement
seekingalpha.com - July 12 at 8:19 AM |
| Xenon Pharmaceuticals Announces At-The-Market Equity Offering
finance.yahoo.com - July 12 at 8:19 AM |
| A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
feeds.benzinga.com - July 5 at 1:34 PM |
| Form SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLC
www.streetinsider.com - July 3 at 5:08 PM |
| Xenon Pharma +3.9% as Potiga gets orphan drug status
seekingalpha.com - June 25 at 5:37 PM |
| Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111
feeds.benzinga.com - June 13 at 8:20 AM |
| Xenon Pharma continues northward march, up 15%
seekingalpha.com - June 12 at 5:03 PM |
| 41 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - June 12 at 1:20 PM |
| Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
finance.yahoo.com - June 1 at 5:43 PM |
| Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?
seekingalpha.com - May 30 at 5:19 PM |
| Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference
finance.yahoo.com - May 17 at 8:24 AM |
| Xenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - Slideshow
seekingalpha.com - May 16 at 5:40 PM |
